急性虚血発作（Acute Ischemic Stroke）：グローバル臨床試験動向（2014年上半期）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Acute Ischemic Stroke 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Acute Ischemic Stroke to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Acute Ischemic Stroke to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Acute Ischemic Stroke 25
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Acute Ischemic Stroke Therapeutics Clinical Trials 32
Prominent Drugs 34
Latest Clinical Trials News on Acute Ischemic Stroke 35
Apr 22, 2014: ZZ Biotech Announces Phase 2 Trial with 3K3A-APC in Stroke; Funds Will Be Provided by NIH and Broadview Ventures 35
Mar 04, 2014: D-Pharm reports the successful interim analysis of its Phase 2 clinical study of THR-18 in acute stroke patients 36
Clinical Trial Profiles 37
Clinical Trial Overview of Top Companies 37
H. Lundbeck A/S 37
Clinical Trial Overview of H. Lundbeck A/S 37
Daiichi Sankyo Company, Limited 38
Clinical Trial Overview of Daiichi Sankyo Company, Limited 38
Sanofi 39
Clinical Trial Overview of Sanofi 39
Novartis AG 40
Clinical Trial Overview of Novartis AG 40
Mitsubishi Chemical Holdings Corporation 41
Clinical Trial Overview of Mitsubishi Chemical Holdings Corporation 41
D-Pharm Ltd. 42
Clinical Trial Overview of D-Pharm Ltd. 42
AstraZeneca PLC 43
Clinical Trial Overview of AstraZeneca PLC 43
Paion AG 44
Clinical Trial Overview of Paion AG 44
F. Hoffmann-La Roche Ltd. 45
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 45
C. H. Boehringer Sohn AG & Co. KG 46
Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 46
Clinical Trial Overview of Top Institutes / Government 47
Seoul National University Hospital 47
Clinical Trial Overview of Seoul National University Hospital 47
Hallym University Medical Center 49
Clinical Trial Overview of Hallym University Medical Center 49
National Institute of Neurological Disorders and Stroke 50
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 50
Xijing Hospital 51
Clinical Trial Overview of Xijing Hospital 51
Charite – Universitatsmedizin Berlin 52
Clinical Trial Overview of Charite – Universitatsmedizin Berlin 52
The University of Texas Health Science Center at Houston 53
Clinical Trial Overview of The University of Texas Health Science Center at Houston 53
Kawasaki Medical University 54
Clinical Trial Overview of Kawasaki Medical University 54
University of Cincinnati 55
Clinical Trial Overview of University of Cincinnati 55
Yonsei University 56
Clinical Trial Overview of Yonsei University 56
Erasmus MC 57
Clinical Trial Overview of Erasmus MC 57
Five Key Clinical Profiles 58
Appendix 75
Abbreviations 75
Definitions 75
Research Methodology 76
Secondary Research 76
About GlobalData 77
Contact Us 77
Disclaimer 77
Source 77